News summary

UCLA lands $25m to test dementia AI tools

Source: Longevity Technology • Published: 07 Oct 2026, 16:10

Summarized by Masters of Longevity from Longevity Technology.

A piece about a university-led program that will evaluate AI diagnostic and care tools for dementia, outlining its goals and national relevance.

UCLA lands $25m to test dementia AI tools
Key Takeaways
  • UCLA Health received a five-year $25 million grant from the National Institute on Aging to lead the program.
  • The initiative will develop evaluation frameworks and safety monitoring standards to be shared nationally through the NIA network.
  • The team will test existing AI dementia tools across the UC system and partner institutions to assess performance in diverse care settings.
Read the full article at Longevity Technology ↗

Continue exploring

Recommended MoL Picks

MoL PickApple Brings Longevity to the Wrist. What Will It Change?Apple’s new Health Age, readiness and movement tools bring long-term health into everyday view. The opportunity is turning that information into useful action.MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.